These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8344853)

  • 1. The differential induction of collateral resistance to 62.5 MeV (p-->Be+) neutrons and 4 MeV photons by exposure to cis-platinum.
    Britten RA; Warenius HM; Masters JR; Peacock JH
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):837-43. PubMed ID: 8344853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collateral resistance to photon and neutron irradiation is associated with acquired cis-platinum resistance in human ovarian tumour cells.
    Britten RA; Peacock J; Warenius HM
    Radiother Oncol; 1992 Mar; 23(3):170-5. PubMed ID: 1574595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo cisplatinum resistance does not influence cellular radiosensitivity.
    Britten RA; Warenius HM
    Eur J Cancer; 1993; 29A(9):1315-20. PubMed ID: 8343276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of hypoxia on the relative sensitivity of human tumor cells to 62.5 MeV (p-->Be) fast neutrons and 4 MeV photons.
    Warenius HM; White R; Peacock JH; Hanson J; Britten RA; Murray D
    Radiat Res; 2000 Jul; 154(1):54-63. PubMed ID: 10856966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human in vitro cell lines with greater intrinsic cellular radiosensitivity to 62.5 MeV (p-->Be+) neutrons than 4 MeV photons.
    Warenius HM; Britten RA; Browning PG; Morton IE; Peacock JH
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):913-20. PubMed ID: 8138445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the potential therapeutic gain of p(66)/Be neutrons and d(14)/Be neutrons.
    Slabbert JP; Theron T; Zolzer F; Streffer C; Bohm L
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1059-65. PubMed ID: 10863079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inherent cellular sensitivity to 62.5 MeV(p----Be+) neutrons of human cells differing in photon sensitivity.
    Britten RA; Warenius HM; Parkins C; Peacock JH
    Int J Radiat Biol; 1992 Jun; 61(6):805-12. PubMed ID: 1351531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative cellular radiosensitivity of 30 human in vitro cell lines of different histological type to high LET 62.5 MeV (p-->Be+) fast neutrons and 4 MeV photons.
    Warenius HM; Britten RA; Peacock JH
    Radiother Oncol; 1994 Jan; 30(1):83-9. PubMed ID: 8153385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies of intrinsic cellular radiosensitivity following 4 MeV photons or 62.5 MeV (p-->Be+) neutrons. Potential implications for high LET therapy.
    Warenius HM; Britten RA
    Acta Oncol; 1994; 33(3):241-9. PubMed ID: 8018352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melphalan resistant human ovarian tumour cells are cross-resistant to photons, but not to high LET neutrons.
    Britten RA; Warenius HM; White R; Browning PG; Green JA
    Radiother Oncol; 1990 Aug; 18(4):357-63. PubMed ID: 2244022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V79 survival following simultaneous or sequential irradiation by 15-MeV neutrons and 60Co photons.
    Higgins PD; DeLuca PM; Pearson DW; Gould MN
    Radiat Res; 1983 Jul; 95(1):45-56. PubMed ID: 6878632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic transformation of C3H 10T1/2 cells by acute and protracted exposures to monoenergetic neutrons.
    Miller RC; Hall EJ
    Radiat Res; 1991 Oct; 128(1 Suppl):S60-4. PubMed ID: 1924750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
    Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of mutation induction on fast-neutron energy in a human epithelial teratocarcinoma cell line (P3).
    Sharma S; Hill CK
    Radiat Res; 1996 Mar; 145(3):331-6. PubMed ID: 8927701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitivity variations in human tumor cell lines exposed in vitro to p(66)/Be neutrons or 60Co gamma-rays.
    Slabbert JP; Theron T; Serafin A; Jones DT; Böhm L; Schmitt G
    Strahlenther Onkol; 1996 Oct; 172(10):567-72. PubMed ID: 8899008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-fractionation studies on mouse gut and marrow: an intercomparison of 6-MeV photons and fast neutrons (E = 25 MeV).
    Redpath JL; David RM; Cohen L
    Radiat Res; 1978 Sep; 75(3):642-8. PubMed ID: 724991
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiobiological studies with therapeutic neutron beams generated by p+ leads to Be or d+ leads to Be.
    Hall EJ; Zaider M; Bird R; Astor M; Roberts W
    Br J Radiol; 1982 Sep; 55(657):640-4. PubMed ID: 6289956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutron-energy-dependent cell survival and oncogenic transformation.
    Miller RC; Marino SA; Martin SG; Komatsu K; Geard CR; Brenner DJ; Hall EJ
    J Radiat Res; 1999 Dec; 40 Suppl():53-9. PubMed ID: 10804994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
    Mellish KJ; Kelland LR; Harrap KR
    Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neutron component of two high-energy photon reference fields.
    Röttger S; Schäler K; Behrens R; Nolte R; Wissmann F
    Radiat Prot Dosimetry; 2007; 126(1-4):404-7. PubMed ID: 17675300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.